Is it possible to reduce the rate of vertical transmission and improve perinatal outcomes by inclusion of remdesivir in treatment regimen of pregnant women with COVID–19?

BACKGROUND: Coronavirus disease 2019 (COVID–19) is currently one of the world's most critical health issues so far. Given the importance of appropriate treatment in pregnancy and the controversies about Remdesivir effectiveness and complications, the present study aimed to evaluate the impact o...

Descripción completa

Detalles Bibliográficos
Autores principales: Tavakoli, Nader, Chaichian, Shahla, Sadraei, Jamileh Sadat, Sarhadi, Saeedeh, Bidgoli, Sepideh Arbabi, Rokhsat, Elnaz, Anoushirvani, Katayoon, Nikfar, Banafsheh, Mehdizadehkashi, Abolfazl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923661/
https://www.ncbi.nlm.nih.gov/pubmed/36782188
http://dx.doi.org/10.1186/s12884-023-05405-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923661/
https://www.ncbi.nlm.nih.gov/pubmed/36782188
http://dx.doi.org/10.1186/s12884-023-05405-y

Ejemplares similares